General - Press Releases

Date	Title	Company
17-Oct-2023	Merck Receives Positive EU CHMP Opinion for PREVYMIS® for Prevention of CMV Disease in High-Risk Adult Kidney Transplant Recipients and Extended 200-Day Dosing in Adult HSCT Recipients at Risk for Late CMV Infection and Disease	Businesswire
17-Oct-2023	SpliceBio Enters Collaboration with Spark Therapeutics to Develop a Gene Therapy Targeting an Inherited Retinal Disease	SpliceBio
17-Oct-2023	Poolbeg Pharma Partners with a Nasdaq-Listed Biopharma Company on its Oral Delivery Platform	Poolbeg Pharma
17-Oct-2023	Manual programming preventing rapid rollout of robots for over half of UK manufacturers	Visual Components
17-Oct-2023	Johnson & Johnson Reports Q3 2023 Results	Businesswire
17-Oct-2023	Rancho Biosciences Earns Prestigious 'Great Place to Work' Certification for the Second Consecutive Year	Newswire
17-Oct-2023	Rockwell Medical Appoints Joan Lau, Ph.D. to the Company's Board of Directors	Businesswire
17-Oct-2023	Healthwell Acquisition Corp. I Announces New Meeting Date for the Special Meeting of Stockholders to Approve Proposed Business Combination With Starton Therapeutics, Inc. and Related Transactions	Businesswire
17-Oct-2023	Diakonos Oncology Awarded FDA Fast Track Designation for Innovative Dendritic Cell Vaccine for Glioblastoma	Businesswire
17-Oct-2023	Moolec Science Announces Capital Raise With Strategic Investors for ~US $30 Million	Newswire
17-Oct-2023	Hewlett Packard Enterprise Builds AI Supercomputer for CRIANN to Accelerate Scientific Research and Innovation	Businesswire
17-Oct-2023	Blue Earth Diagnostics Ltd Collaborates with Sinotau Pharmaceutical Group to Bring Prostate Cancer PET Diagnostic Imaging Agent, Flotufolastat (18F) Injection, to China	Businesswire
17-Oct-2023	Saphetor Partners with ICON to Develop Innovative Data-centric Approach to Precision Medicine Clinical Trial Strategies to Help Support Unique Patients	Businesswire
17-Oct-2023	MMI Expands Global Footprint with Entry into Asia Pacific Market	Businesswire
17-Oct-2023	Discovery Park and Researcher partner to support scientific collaboration	Discovery Park
17-Oct-2023	Teva Phase IV UNITE Study Shows AJOVY® (fremanezumab) Reduced Migraine Attacks and Depression Symptoms in Migraine Sufferers with Major Depressive Disorder	Businesswire
17-Oct-2023	ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA	ImmunOs Therapeutics
17-Oct-2023	Factbird Enters Sweden with Advanced Manufacturing Solutions	Businesswire
17-Oct-2023	Gunze to Invest 3.5 billion JPY in Establishing Ayabe Plants and R&D Laboratories in Kyoto, Japan for Growth of Medical Business	Businesswire
17-Oct-2023	FDA Approves KEYTRUDA® (pembrolizumab) for Treatment of Patients With Resectable (T≥4 cm or N+) NSCLC in Combination With Chemotherapy as Neoadjuvant Treatment, Then Continued as a Single Agent as Adjuvant Treatment After Surgery	Businesswire